# Winship National Clinical Trials Network Lead Academic Participating Site

> **NIH NIH UG1** · EMORY UNIVERSITY · 2024 · $762,746

## Abstract

Project Summary/Abstract
Winship Cancer Institute of Emory University (Winship) is the only NCI-designated Comprehensive Cancer
Center in the state of Georgia, despite Georgia being the eighth most populous state in the nation. Within
Georgia, cancer is the second leading cause of death, with 48,850 new cancer cases diagnosed each year1.
Since March 1, 2014, when Winship became a NCI National Clinical Trials Network (NCTN) Lead Academic
Participating Site (LAPS), Winship has played a unique role in leading research in the NCTN groups in the four
most important measures of success: 1) Winship has exceeded its enrollment target for NCTN trials; 2)
Winship has provided significant leadership to both the NRG and the ECOG-ACRIN groups; 3) Winship has
been active in designing and supporting clinical trials in all NCTN network groups; and 4) Winship leadership
has been successful in mentoring the next generation of cancer researchers. Winship members are well
represented in the NCI's NCTN steering committees and task forces. Approximately 30% of Winship patients
enrolled to NCTN trials are of African descent. Additionally, Winship has been among the top three centers for
the past four years and the highest in 2016 to enroll children and adolescents with cancer to the Children's
Oncology Group (COG) indicating Winship's leadership in the NCTN. The Atlanta VA Medical Center, currently
an affiliate of our LAPS, was the top enroller to NCTN trials nationally among VA hospitals for the first two
years of the award period. Winship has also leveraged its statewide partnerships with the Georgia National
Community Oncology Research Program (NCORP) and the Georgia minority underserved NCORP to enhance
accruals to NCTN trials throughout Georgia. With an enthusiastic institutional commitment to its role in the
NCTN, Winship proposes the following specific aims for this application: 1) Expand its many leadership roles
within the NCTN and the network groups; 2) Enroll Winship patients onto a wide spectrum of NCTN trials,
emphasizing enrollment of historically under-represented minority patients; 3) Provide mentorship and
guidance to early career investigators for participation in the NCTN; and 4) Develop novel clinical trials in the
NCTN based on research ideas generated at Winship.

## Key facts

- **NIH application ID:** 10794371
- **Project number:** 5UG1CA233247-06
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Ashesh Jani
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $762,746
- **Award type:** 5
- **Project period:** 2019-03-05 → 2026-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10794371

## Citation

> US National Institutes of Health, RePORTER application 10794371, Winship National Clinical Trials Network Lead Academic Participating Site (5UG1CA233247-06). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10794371. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*